| 缩写名/全名 |
RECENT PAT ANTI-CANC
Recent Patents on Anti-Cancer Drug Discovery |
||||||||||||||||||||||||||||
| ISSN号 | 1574-8928 | ||||||||||||||||||||||||||||
| 研究方向 | 医学-药学 | ||||||||||||||||||||||||||||
| 影响因子 | 2015:3.533, 2016:2.956, 2017:2.509, 2018:2.121, 2019:2.61, | ||||||||||||||||||||||||||||
| 出版国家 | U ARAB EMIRATES | ||||||||||||||||||||||||||||
| 出版周期 | Tri-annual | ||||||||||||||||||||||||||||
| 年文章数 | 26 | ||||||||||||||||||||||||||||
| 出版年份 | 2006 | ||||||||||||||||||||||||||||
| 是否OA | No | ||||||||||||||||||||||||||||
| 审稿周期(仅供参考) | 平均3.0个月 |
||||||||||||||||||||||||||||
| 录用比例 | 较易 | ||||||||||||||||||||||||||||
| 投稿链接 | http://bsp-cms.eurekaselect.com/index.php/PRA/login?source=%2Findex.php%2FPRA | ||||||||||||||||||||||||||||
| 投稿官网 | http://www.recentpatentsonanticancerdrugdiscovery.com/ | ||||||||||||||||||||||||||||
| h-index | 36 | ||||||||||||||||||||||||||||
| CiteScore |
|
||||||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1574-8928%5BISSN%5D | ||||||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2018年新版本） |
|
||||||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年新版本） |
|
| 中国学者近期发表的论文 | |
| 1. | High-throughput Strategy Accelerates the Progress of Marine Anticancer Peptide Drug Development. Author: Lyu P1, Kwok HF1. Journal: Recent Pat Anticancer Drug Discov. 2019;14(1):2-4. doi: 10.2174/1574892813999181114152127. PubMed DOI |
| 2. | Chimeric Antigen Receptor T Cell Immunotherapy for Tumor: A Review of Patent Literatures Author: Fu M1, Tang L1. Journal: Recent Pat Anticancer Drug Discov. 2019;14(1):60-69. doi: 10.2174/1574892814666190111120908. PubMed DOI |
| 3. | From Antimicrobial to Anticancer Peptides: The Transformation of Peptides. Author: Qin Y1,2, Qin ZD1, Chen J3, Cai CG4, Li L1, Feng LY1, Wang Z1, Duns GJ1, He NY2, Chen ZS5, Luo XF1. Journal: Recent Pat Anticancer Drug Discov. 2019;14(1):70-84. doi: 10.2174/1574892814666190119165157. PubMed DOI |
| 4. | Enzyme and Transporter Kinetics for CPT-11 (Irinotecan) and SN-38: An Insight on Tumor Tissue Compartment Pharmacokinetics Using PBPK. Author: Fan Y1,2, Mansoor N3, Ahmad T4, Wu ZX2, Khan RA3, Czejka M5, Sharib S4, Ahmed M6, Chen ZS2, Yang DH2. Journal: Recent Pat Anticancer Drug Discov. 2019 Feb 12. doi: 10.2174/1574892814666190212164356. [Epub ahead of print] PubMed DOI |
| 5. | Inhibitory effect of hydroxysafflower yellow B on the proliferation of human breast cancer MCF-7 cells. Author: Qu C1, Zhu W1, Dong K2, Pan Z1, Chen Y1, Chen X1, Liu X1, Xu W1, Lin H1, Zheng Q1, Li D1. Journal: Recent Pat Anticancer Drug Discov. 2019 May 15. doi: 10.2174/1574891X14666190516102218. [Epub ahead of print] PubMed DOI |
| 6. | Decreased Expression of Caveolin-1 and E-Cadherin Correlates with the Clinicopathologic Features of Gastric Cancer and the EMT Process. Author: Zhang K, Yang G, Wu W, Zhang J, Xia X, Jiang T, Cao J, Huang K, Qiu Z, Huang C. Journal: Recent Pat Anticancer Drug Discov. 2016;11(2):236-44. PubMed |
| 7. | Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment. Author: Huang L, He R, Luo W, Zhu YS, Li J, Tan T, Zhang X, Hu Z, Luo D. Journal: Recent Pat Anticancer Drug Discov. 2016;11(2):184-96. PubMed |
| 8. | Predictive Efficacy Biomarkers of Programmed Cell Death 1/Programmed Cell Death 1 Ligand Blockade Therapy. Author: Fang XN, Fu LW. Journal: Recent Pat Anticancer Drug Discov. 2016;11(2):141-51. PubMed |
| 9. | Isoliquiritigenin Inhibits Proliferation and Induces Apoptosis via Alleviating Hypoxia and Reducing Glycolysis in Mouse Melanoma B16F10 Cells. Author: Wang Y, Ma J, Yan X, Chen X, Si L, Liu Y, Han J, Hao W, Zheng Q. Journal: Recent Pat Anticancer Drug Discov. 2016;11(2):215-27. PubMed |
| 10. | Application of nanotechnology in the diagnosis and therapy of hepatocellular carcinoma. Author: Hou XY, Jiang G, Yang CS, Tang JQ, Wei ZP, Liu YQ. Journal: Recent Pat Anticancer Drug Discov. 2016 Mar 9. [Epub ahead of print] PubMed |
|
|
